Zaffaroni, Alejandro

(redirected from Alejandro Zaffaroni)
Also found in: Wikipedia.

Zaffaroni,

Alejandro, Uruguayan-U.S. chemist and biochemist, 1923–.
Zaffaroni system - a chromatographic system for the separation of steroids.
References in periodicals archive ?
Alejandro Zaffaroni, where he served as managing director and president of the Pharma Division.
BC: Of the many people I admire, one of my heroes within this industry is Alejandro Zaffaroni, the architect of Alza, Affymetric and several other highly successful drug companies.
Invitrogen is also sponsor of the Chemical Heritage Foundation and BIO's 8th Annual Biotechnology Heritage Award, which will be given to industry pioneer Alejandro Zaffaroni, founder of several biotechnology companies and someone who truly exemplifies innovation.
Alejandro Zaffaroni Health Award for improving health in developing nations by creating sterile pre-filled, single-use syringes for vaccines, that are easy to administer and cannot be reused.
The financing was led by the Sprout Group and co-led by Tavistock Life Sciences, and included CMEA Ventures, Lombard Odier & Cie, Novartis BioVenture Fund, Aravis Ventures, Alejandro Zaffaroni, and the Singapore Economic Development Board, among others.
Among those Rosenkranz recruited from outside the country were Juan Pataki, a Hungarian trained in Switzerland by Ruzicka; Esteban Kaufmann, a longtime friend and colleague who also was trained by Ruzicka; Carl Djerassi, an Austrian refugee who at 26 year old Austrian who was acquiring professional fame through his prolific writings and research; and Alejandro Zaffaroni, a Uruguayan who had earned an international reputation for his work demonstrating the applicability of paper chromatography to steroids.
Alejandro Zaffaroni, have signed new Voluntary Extended Lock-up Agreements with the Company representing approximately 41%, or approximately 26.
The private placement was led by MPM Asset Management and included Versant Ventures, Chemicals and Materials Enterprise Associates (CMEA), Bay City Capital, Lombard Odier & Cie, and Alejandro Zaffaroni.